Prexige

Canada Bans Anti-Inflammatory Drug Prexige after Reports of Severe Liver Damage

Monday, March 03, 2008 by: David Gutierrez, staff writer
Tags: Prexige, health news, Natural News

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
The five biggest lies about Ebola being pushed by government and mass media
Why does the CDC own a patent on Ebola 'invention?'
White House admits staging fake vaccination operation to gather DNA from the public
Ultraviolet light robot kills Ebola in two minutes; why doesn't every hospital have one of these?
EXCLUSIVE: Natural News tests flu vaccine for heavy metals, finds 25,000 times higher mercury level than EPA limit for water
Truvia sweetener a powerful pesticide; scientists shocked as fruit flies die in less than a week from eating GMO-derived erythritol
Irrefutable proof we are all being sprayed with poison: 571 tons of toxic lead 'chemtrailed' into America's skies every year
Tetanus vaccines found spiked with sterilization chemical to carry out race-based genocide against Africans
Russia taking McDonald's to court, threatens countrywide shutdown
Oregon man serving prison sentence for collecting rainwater on his own property
The best way to help your body protect itself against Ebola (or any virus or bacteria)
Global warming data FAKED by government to fit climate change fictions
Senator who attacked Doctor Oz over dietary supplements received over $146,000 in campaign contributions from Big Pharma mega-retailer and Monsanto
Healthy 12-year-old girl dies shortly after receiving HPV vaccine
Ebola outbreak may already be uncontrollable; Monsanto invests in Ebola treatment drug company as pandemic spreads
HOAX confirmed: Michelle Obama 'GMOs for children' campaign a parody of modern agricultural politics
Ben & Jerry's switches to non-GMO, Fair Trade ice cream ingredients
W.H.O. contradicts CDC, admits Ebola can spread via coughing, sneezing and by touching contaminated surfaces

Delicious
(NaturalNews) Canada's government health agency, Health Canada, has announced the withdrawal of market authorization for non-steroidal anti-inflammatory lumiracoxib due to evidence connecting the drug to severe liver damage.

Health Canada requested that Novartis stop selling lumiracoxib, marketed as Prexige, and the company has complied with the request.

Prexige is used primarily to treat osteoarthritis patients, and has been approved for sale in 21 countries. The drug's troubles began in August when the Therapeutic Goods Administration of Australia withdrew its approval for Prexige after reviewing evidence on 8 reports of severe liver damage arising from use of the drug. This included two deaths and two liver transplants. Following Australia's decision, New Zealand also pulled the drug from the market.

According to Health Canada, there have been two confirmed cases of liver-related complications from Prexige in Canada. The agency reviewed additional safety information provided by Novartis, and concluded that "the risk of serious hepatotoxicity associated with the use of Prexige cannot be safely and effectively managed."

Health Canada advised all doctors and pharmacists to discontinue prescribing Prexige, return all samples, and discuss new treatment options with patients currently on the drug. It encouraged patients to return any supplies of the drug to their pharmacists. "In order to avoid contaminating ground or municipal water systems, the product should not be flushed down the toilet or sink," Health Canada said.

In 2003, the U.S. FDA rejected the trade name "Prexige" for lumiracoxib. The agency has not yet ruled on whether to approve the drug for use and sale in the United States. Likewise, it has not yet been revealed what trade name the drug would use if approved, although "Prexede" has been suggested.

Countries in which Prexige is still approved for use include Argentina, Brazil, Mexico, South Africa and all European Union countries.

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.